Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Johnson & Johnson

Mentioned in 31 analyzed podcast episodes across 10 shows

A major pharmaceutical and healthcare company discussed across business, health, and political podcasts for its innovation strategy, dividend profile, and competitive positioning in the GLP-1 market. Podcast mentions cover its vaccine development history (including a COVID vaccine withdrawn due to safety concerns), involvement in manufacturing contamination issues, and recent negotiations with the Trump administration on drug pricing and domestic manufacturing investments. The company has also been referenced in discussions of broader pharmaceutical industry practices, including pricing pressures from pharmacy benefit managers and corporate influence on health media coverage.

Episode Mentions

BioSpace

BioSpace · May 13, 2026

Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay

CEO Joaquin Duato second highest paid at over $30M; largest healthcare company globally

FDA Commissioner leadership transition and removalRegulatory uncertainty and HHS agency turnoverCommissioner's National Priority Review voucher program
View Analysis
Biotech Hangout

Biotech Hangout · May 8, 2026

Episode 182 - May 8, 2026

Reported combination IBD therapy (finerenone + Symvepend) data that missed primary endpoint but advancing in refractory patients

Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis
DGTL Voices with Ed Marx

DGTL Voices with Ed Marx · May 7, 2026

See the Human Being First (ft. Phoebe Yang)

CIO was guest speaker in Phoebe's Stanford AI class; discussed AI adoption strategy and IT professional development

AI Safety and Guardrails in HealthcareHuman-Centered Healthcare Technology DesignTrust-Based Leadership in Healthcare Transformation
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · May 7, 2026

Bayer's $2.4B Perfuse Deal Shakes Up Eye Care | Pharma and Biotech Daily

MedTech division reported successful clinical outcomes from Otava Surgical Robot System in gastric bypass surgeries

Ophthalmology Portfolio ExpansionAI-Driven Drug Development CommercializationGLP-1 Agonist Obesity Treatment Competition
View Analysis
CNBC's "Fast Money"

CNBC's "Fast Money" · May 5, 2026

Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26

Licensing partner for Protagonist's Icotide drug; commercializing psoriasis treatment with $10B peak sales projection

AI Infrastructure Investment and Chip CompetitionCloud Computing Backlog Concentration RiskSemiconductor Market Diversification from NVIDIA
View Analysis
Skin Anarchy

Skin Anarchy · Apr 28, 2026

What “Efficacy” Actually Means in Skincare with Jack Jia of Musely

Parent company of skincare brands, cited as example of big pharma unable to innovate in cosmetic dermatology

FDA cosmetics vs. drug classification and regulatory barriers to efficacy claimsTretinoin efficacy and bioavailability compared to non-prescription retinol productsPrescription compounding pharmacy technology and supply chain optimization
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · Apr 24, 2026

Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily

Partnered with Viz.ai to enhance diagnostic precision in neurovascular applications using AI technology

Gene Therapy Regulation and FDA Approval PathwaysHearing Loss Treatment InnovationGLP-1 Receptor Agonists for Type 2 Diabetes
View Analysis
Mad Money w/ Jim Cramer

Mad Money w/ Jim Cramer · Apr 23, 2026

Mad Money w/ Jim Cramer 4/23/26

Pharmaceutical company with AAA balance sheet and best pipeline of blockbusters; trading under 20x earnings

Enterprise Software Valuation CollapseAI Displacement Risk in SaaSHealthcare Stocks as Value Plays
View Analysis
The a16z Show

The a16z Show · Apr 23, 2026

Martin Shkreli on AI, Pharma, and What Actually Matters

Used as example of company more stable than sovereign nations; diversified healthcare portfolio across pharma, med tech, consumer health

Photonic Computing and Optical HardwareAI Model Commoditization vs. Economic Value CaptureOpenAI vs. Anthropic Monetization Strategy
View Analysis
Wall Street Breakfast

Wall Street Breakfast · Apr 23, 2026

ServiceNow tanks on margins

Holding annual shareholder meeting with votes on safer pay and independent board chair proposals

Enterprise Software Margin CompressionGeopolitical Impact on B2B RevenueHumanoid Robot Production Scaling
View Analysis
The iDesign Lab Podcast | Where Design, Business, and Culture Shape How We Live and Build

The iDesign Lab Podcast | Where Design, Business, and Culture Shape How We Live and Build · Apr 23, 2026

How Virtual Interior Design Is Making Luxury Spaces More Accessible, Scalable, and Client-Driven

Large corporation where Christy worked in medical sales and marketing for 20-25 years before launching design business

Virtual interior design service models and deliveryFlat-rate vs. hourly pricing for design servicesEntry-level luxury design market segmentation
View Analysis
The Dr. Hyman Show

The Dr. Hyman Show · Apr 20, 2026

Can’t Fall or Stay Asleep? Your Sleep Questions Answered

Referenced for their baby bath product containing lavender, cited as evidence that lavender lowers cortisol

Circadian Rhythm OptimizationBlood Sugar Stability and SleepNervous System Regulation and Stress Management
View Analysis
The Rich Roll Podcast

The Rich Roll Podcast · Apr 20, 2026

In Waves & War: Marcus & Amber Capone On Psychedelic Treatment For Veteran PTSD, Rebuilding Life After War & The Mission To Heal A Generation

Pharmaceutical company entering psychedelic market after startup validation and Phase 2 clinical success

Ibogaine and Iboga plant medicine: extraction, dosing, cardiac risk management, and ceremonial protocolsPTSD and TBI in military populations: blast exposure, compartmentalization, and neurological damage from repeated deploymentsPsychedelic integration coaching: post-treatment behavioral work, neural pathway creation, and 90-day critical window
View Analysis
Morning Brew Daily

Morning Brew Daily · Apr 13, 2026

US Plans Hormuz Blockade & Wall Street Bigwigs Nervous About Mythos

Reporting Q1 earnings this week as part of earnings season coverage

Strait of Hormuz Blockade StrategyIran Nuclear NegotiationsOil Price Volatility and Energy Markets
View Analysis
Mad Money w/ Jim Cramer

Mad Money w/ Jim Cramer · Apr 10, 2026

Mad Money w/ Jim Cramer 4/10/26

Cramer's favorite pharma stock; transformed company with strong pipeline; typically rallies post-earnings call

Iran Ceasefire Geopolitical RiskDefense Contractor Stock ValuationsMissile and Munitions Supply Chain
View Analysis
A Beginner's Guide to AI

A Beginner's Guide to AI · Apr 1, 2026

How to Invest in AI Without Getting Fooled by Hype, with Talullah Le Merle

Named as FTSE 100 client during speaker's consulting work on digital transformation

AI Investment Criteria and Due DiligenceAI Ethics and Human Values AlignmentAI Job Displacement and Workforce Transition
View Analysis
Global News Podcast

Global News Podcast · Mar 10, 2026

Hegseth: Today ‘most intense’ day of US strikes on Iran

Named in major UK class action lawsuit, exemplifying rising litigation exposure for multinational corporations

US-Iran Military EscalationStrait of Hormuz Oil Supply DisruptionGlobal Oil Price Volatility
View Analysis
Adam Carolla Show

Adam Carolla Show · Mar 3, 2026

Why the Government Lied about COVID w/ Gavin de Becker

Baby powder manufacturer that disclosed asbestos content to FDA in 1980s but wasn't forced to eliminate it until 2023

COVID-19 Lockdown Policy EffectivenessGovernment Narrative Control and DisinformationVaccine Safety and Long-Term Testing Protocols
View Analysis
Motley Fool Money

Motley Fool Money · Feb 22, 2026

How to Spot Winning Innovation

Mentioned as Fortune 500 company that Lorraine Marchand has advised on innovation strategy

Innovation Framework and StrategyOrganizational Culture and Psychological SafetyRisk Management and Strategic vs. Reckless Risk
View Analysis
Mad Money w/ Jim Cramer

Mad Money w/ Jim Cramer · Feb 5, 2026

Mad Money w/ Jim Cramer 2/4/26

Solid pharma earner with strong dividend and buyback profile; competing in GLP-1 space

GLP-1 Drug Competition and Pricing StrategyEnterprise Software Industry Disruption by AIMarket Rotation from Growth to Value Stocks
View Analysis
Therapist Uncensored Podcast

Therapist Uncensored Podcast · Feb 3, 2026

Nontoxic Guide to Healthy Living with Dr. Aly Cohen (290)

Referenced as corporate sponsor influencing media coverage of environmental health research

Environmental toxins and chemical exposures in consumer productsAutoimmune disease epidemiology and rising incidence ratesEndocrine-disrupting chemicals and immune-disrupting chemicals
View Analysis
Congressional Dish

Congressional Dish · Jan 31, 2026

CD331: December 2025 — Authorizing Future Disasters

Produced contaminated vaccine doses from Emergent BioSolutions contract overseen by Robert Kadlec

Aviation Safety Regulation and Mid-Air Collision PreventionNational Defense Authorization Act (NDAA) Provisions and LoopholesEnvironmental Deregulation and Federal Land Protection
View Analysis
Leaked

Leaked · Jan 27, 2026

Redfield on Risk: Gain-of-Function, Bird Flu, and the Next Pandemic

COVID vaccine developer; vaccine withdrawn from market due to blood clot side effects

COVID-19 Lab Origin Theory and Wuhan Institute of VirologyGain-of-Function Research Regulation and EnforcementmRNA Vaccine Safety and Adverse Events
View Analysis
The Al Franken Podcast

The Al Franken Podcast · Jan 25, 2026

Wendell Potter on The Healthcare Crisis

Pharmaceutical company subject to PBM rebate demands; example of drug maker forced to pay kickbacks to PBMs for formulary placement

Prior Authorization Denials and Patient HarmMedical Loss Ratio Circumvention StrategiesPharmacy Benefit Manager Market Consolidation
View Analysis
The Rest Is History

The Rest Is History · Jan 22, 2026

637. Revolution in Iran: Rise of the Ayatollah (Part 2)

Had factories and investments in Iran facing losses due to revolution

Iranian Revolution of 1979Ayatollah Khomeini and Islamic theologyVelayat-e-Faqih (guardianship of the jurist)
View Analysis
Squawk Pod

Squawk Pod · Jan 9, 2026

Internet Blackout in Iran & Protests in Minneapolis 1/9/26

Reached deal with Trump administration to cut drug prices in exchange for tariff exemptions; announced $55B U.S. investment including two new manufacturing facilities

Iran Internet Blackout and Protest ResponseICE Immigration Enforcement and Minneapolis ShootingCalifornia Wealth Tax Proposal and Opposition
View Analysis
The Dylan Gemelli Podcast

The Dylan Gemelli Podcast · Dec 29, 2025

Episode #76 Featuring Shanna Pearson! A MASTERCLASS on ADHD! Impact of ADHD on life and relationships, Misdiagnosis of ADHD, ADHD vs. Anxiety, Recognizing ADHD signs and more!

Named as world-class institution receiving Shanna's executive coaching services

ADHD diagnosis and misdiagnosis in adultsDopamine deficiency as neurological basis for ADHDADHD vs. anxiety disorder symptom overlap
View Analysis
The Vault Unlocked

The Vault Unlocked · Nov 5, 2025

The $25 Billion Infomercial Empire Story

Trudeau exposed talcum powder cancer risks in baby powder 20+ years before product was banned from market

Infomercial Marketing and Direct Response AdvertisingGovernment Regulatory Capture and FDA/FTC EnforcementManifestation Techniques and Goal-Setting Algorithms
View Analysis
Starter Story

Starter Story · Sep 26, 2025

I Became A Venture Capitalist With Only $1,000 | Starter Story

Alex's first post-college employer where he worked in medical device sales before transitioning to startups

Syndicate structure and mechanicsSpecial Purpose Vehicles (SPVs)Deal sourcing strategies
View Analysis
The Code To Winning

The Code To Winning · Sep 6, 2025

BLUEPRINT TO BUILDING A 9 FIGURE BUSINESS || JAMIL FRAZIER || EPISODE 054

Jamil's first corporate job in pharmaceutical sales before launching his entrepreneurial journey

Personal Responsibility and Mindset ShiftsDepression and Mental Health RecoverySix-Figure to Seven-Figure Income Scaling
View Analysis
Proven Podcast

Proven Podcast · Aug 20, 2025

The Most Expensive Mistake Money Can't Fix - Kevin Trudeau

Removed talcum powder (baby powder) from market after Trudeau's earlier warnings proved accurate

Building businesses from zero capitalAuthentic marketing and product positioningHealth optimization for business performance
View Analysis